G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P, van Rees DJ, van Zogchel LMJ, Klein B, Bouti P, Olsman H, Schornagel K, Kok I, Sunak A, Leeuwenburg K, Timmerman I, Dierselhuis MP, Kholosy WM, Molenaar JJ, van Bruggen R, van den Berg TK, Kuijpers TW, Matlung HL, Tytgat GAM, Franke K.
Martinez Sanz P, et al. Among authors: timmerman i.
J Immunother Cancer. 2021 May;9(5):e002259. doi: 10.1136/jitc-2020-002259.
J Immunother Cancer. 2021.
PMID: 34049929
Free PMC article.